Chiyachantana Mr.Chiraphol Chiyachantana Ms.Kusuma Palaprom Two of these four directors jointly sign and seal of the Company. Mr.Chirasak Chiyachantana Mrs.Sangsri Chiyachantana Ms. Jatechanya Boonchaleo Two of
partial tender offer of the business under Chapter 5 of the SEC Notification No. ThorJor. 12/2554. 1 In case of shares, regardless of class or issue, the total number of outstanding securities = ordinary
already received the payments from the purchaser for the outstanding amount. For the three-month period financial statement ended June 30, 2017, the Company recorded lower Finance cost than the Finance cost
for the outstanding amount. For the three-month period financial statement ended September 30, 2017, the Company recorded lower Finance cost than the Finance cost in the same period ended September 30
goods to the outstanding customers at the end of the year. As a result, the performance for the first quarter of 2018 is as follows. - Sales increased from Baht 63.14 million in the first quarter of 2017
policymaking, coordination, oversight or other key responsibilities, for the 4th year; (2) Outstanding Organization on Government Data Governance Award; (3) Outstanding
% of paid up capital, Total investment 50 Millions baht. The acquisition of BS Myco Biotech shares will result in the BS Myco Biotech being a subsidiary of the Company. The Company signed the share
seminar co-hosted by PAPC, SEC, Faculty of Law, CU, FPTI and ACIOA shows the vigorous sign that all sectors place importance to and recognize benefits of personal data protection. In addition, the first
add details, conditions, and execute, negotiate, agree, sign and amend any agreements, applications, evidence and documents relating to the disposal of the Company’s assets, including contact and filing